Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 1

NCT01663987 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

79

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: tiotropium bromide
DRUG: Placebo

Sponsor

Boehringer Ingelheim